Enhanced Precision in Liver Stiffness Measurement with 3D MR Elastography

A recent study published in Radiology explores the advantages and challenges of using three-dimensional magnetic resonance elastography (3D MRE) instead of the conventional two-dimensional method to assess liver stiffness in severely obese adults. The research highlights notable advancements in precision linked to 3D MRE, but also underscores certain operational trade-offs.

In patients with severe obesity, 3D MRE demonstrated superior precision in measuring liver stiffness compared to the traditional 2D approach. This finding is critical considering the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in such patients, a condition that can progress to more severe forms like metabolic dysfunction-associated steatohepatitis (MASH) if untreated.

The research, conducted by a team at the University of Wisconsin-Madison and the University of California, San Diego, evaluated the performance of MRE in extremely obese individuals undergoing weight loss surgery. The study determined that 3D MRE provided better repeatability and reproducibility across different MR system field strengths, particularly at 3.0 T, when compared to 2D MRE.

"3D MRE captures wave motion over the entire liver by recording shear waves in three dimensions, offering a broader 'wavefield' than that of the 2D MRE," explained Dr. Scott Reeder, radiologist at the University of Wisconsin-Madison. The enhanced precision of this technique can help minimize variability in stiffness measurements, which is critical near clinically significant thresholds and prevents misclassification of fibrosis stages.

Despite its advantages, 3D MRE comes with a higher technical failure rate (4.9% vs. 2.9% for 2D MRE) and requires more breath-holds. "While 3D MRE offers higher precision, it does demand more from the patient in terms of breath-holding, which contributes to its higher technical failure rate," added Dr. Reeder.

Furthermore, 3D MRE still needs extensive validation for use across multiple sites and different equipment manufacturers. H. Harry Hu, PhD from the Mayo Clinic, emphasized the necessity for 3D MRE to meet the precision standards long established by 2D MRE to ensure widespread clinical acceptance.

Although 3D MRE presents significant precision benefits, Dr. Reeder cautions against dismissing 2D MRE, suggesting that it remains a viable alternative in scenarios where 3D MRE is less feasible. Future directions for 3D MRE may include finding unique applications where its enhanced capabilities significantly impact clinical decision-making. This approach could broaden its utility beyond liver stiffness quantification and into the analysis of other organs, thereby solidifying its role in routine clinical practice.